CN108047484A - The preparation method and application of camptothecine microballoon - Google Patents

The preparation method and application of camptothecine microballoon Download PDF

Info

Publication number
CN108047484A
CN108047484A CN201711077310.3A CN201711077310A CN108047484A CN 108047484 A CN108047484 A CN 108047484A CN 201711077310 A CN201711077310 A CN 201711077310A CN 108047484 A CN108047484 A CN 108047484A
Authority
CN
China
Prior art keywords
camptothecine
microballoon
template molecule
preparation
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711077310.3A
Other languages
Chinese (zh)
Inventor
程杏安
蒋旭红
刘展眉
吴波
叶静敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhongkai University of Agriculture and Engineering
Original Assignee
Zhongkai University of Agriculture and Engineering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongkai University of Agriculture and Engineering filed Critical Zhongkai University of Agriculture and Engineering
Priority to CN201711077310.3A priority Critical patent/CN108047484A/en
Publication of CN108047484A publication Critical patent/CN108047484A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/26Synthetic macromolecular compounds
    • B01J20/268Polymers created by use of a template, e.g. molecularly imprinted polymers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28014Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
    • B01J20/28016Particle form
    • B01J20/28021Hollow particles, e.g. hollow spheres, microspheres or cenospheres
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/04Polymerisation in solution
    • C08F2/06Organic solvent
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • C08F222/1006Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/102Esters of polyhydric alcohols or polyhydric phenols of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00Foams characterised by the foaming process
    • C08J2201/04Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/05Elimination by evaporation or heat degradation of a liquid phase
    • C08J2201/0502Elimination by evaporation or heat degradation of a liquid phase the liquid phase being organic
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2335/00Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Derivatives of such polymers
    • C08J2335/02Characterised by the use of homopolymers or copolymers of esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a kind of preparation method and applications of camptothecine microballoon.For the present invention using methanol, chloroform mixed solvent as pore-foaming agent, MAA is function monomer, and camptothecine is template molecule, and EGDMA is crosslinking agent, and azodiisobutyronitrile is initiator, and camptothecine microballoon is made in water-bath vibration polymerization.Synthesizing obtained microballoon has higher adsorptivity, and in the case where concentration is 1mmol/L, adsorbance is up to 62.45 μm of ol/g;With good affine performance, higher Selective adsorption is shown, separation factor α is up to 2.09.Camptothecin molecule trace micro-sphere method prepared by the present invention is simple for process, and good high selection sorptive material can be provided for camptothecin analogues.

Description

The preparation method and application of camptothecine microballoon
Technical field
The present invention relates to the preparing technical field of molecular engram microsphere, more particularly, to a kind of system of camptothecine microballoon Preparation Method and application.
Background technology
Camplotheca acuminata is south China specialty plant, and natural resources are extremely limited, and camptothecine has unique anticancer mechanism, clinical The upper treatment for kinds cancer, content of the camptothecine in camplotheca acuminata is very low, and the content highest wherein in fruit of camptotheca acuminata is 0.02%, general yield about 0.008% in root.Low content in addition natural products ingredient complexity to camptothecine extraction and point From bringing big inconvenience.Camptothecine content in camplotheca acuminata is relatively low, system is complicated, separation and concentration difficulty is big while water solubility is low, The features such as effective pharmacophoric group stability is poor, bioavilability is poor limits its clinical research and development.
The development prospect that molecular imprinting technology will have in Separation of Natural Products and purifying.Theoretically if analysis can answer With the molecular imprinting technology with particular molecule identification function, it is polymerize by synthesizing the molecular engram with camptothecine template molecule Object obtains the hole exactly matched with camptothecine and the like function base after eluted template molecule, then is expected to using efficiently point Technology from purifying solves the problems, such as the separating-purifying of camptothecine, to obtain the high anti-cancer activity of high-purity, wide anticancer spectrum Camptothecin analogues.But have no at present can specific aim and high efficiency be applied to camptothecin analogues separating-purifying application Correlation molecule trace object correlative study report.
The content of the invention
It is micro- the technical problem to be solved by the present invention is to be directed to existing camptothecin analogues separating-purifying molecular engram The technical deficiency of ball provides a kind of preparation method of camptothecine microballoon.
Another technical problems to be solved of the present invention are to provide the camptothecine microballoon that the method is prepared.
A present invention also technical problems to be solved are to provide the camptothecine microballoon as camptothecine separating-purifying use point Application in terms of sub- imprinted polymer.
The purpose of the present invention is achieved by the following technical programs:
A kind of preparation method of camptothecine microballoon is provided, is using the mixed solvent of methanol and chloroform as pore-foaming agent, MAA is work( Energy monomer, camptothecine is template molecule, and EGDMA is crosslinking agent, under the action of initiator, dry after water-bath vibration polymerization, It is obtained after elution.
The present invention can be achieved by the way that the amount of methanol in solvent is controlled to control the grain size of microballoon.Methanol content it is more more more The easily microballoon of generation bulky grain.Preferably, the volume ratio of the in the mixed solvent, methanol and chloroform is 5~8:5~2.Into one The volume ratio of the preferred the two of step is 6:4.
The dosage and reaction temperatures affect of the mixed solvent the mobile performance of polymerization system, too small dosage or excessively high Temperature will cause system mobility reduce, product caking, and then influence microballoon absorption property.Preferred solvent dosage be by According to the gauge of 1moL template molecules, the solvent of addition is 15~40mL, is most preferably that solvent dosage is 30mL.
Preferably, the temperature of the polymerization is 50 DEG C~60 DEG C, further preferred 60 DEG C.
Preferably, when the time of the polymerization is 18 small.
Preferably, the dosage of the function monomer is 2~8 according to the mol ratio of itself and template molecule:1 determines.Into one The mol ratio for walking preferred function monomer and template molecule is 4:1 or 5:1.
Preferably, the dosage of the crosslinking agent is 10~30 according to the mol ratio of itself and template molecule:1 determines.Into one The mol ratio for walking preferred crosslinking agent and template molecule is 15:1.
It is highly preferred that the mol ratio of the template molecule, function monomer, crosslinking agent is 1:5:15.Described preferred Under the conditions of optimum proportioning, the microballoon polymerizeing has higher adsorptivity, and in the case where concentration is 1mmol/L, adsorbance is reachable 62.45μmol/g.Preferably, initiator uses azodiisobutyronitrile (AIBN) or azo diamyl cyanogen (ABDV).Further preferably Ground, under the conditions of template molecule is 1mol, the dosage of the initiator is 0.1g.
Preferably, the elution is using V (methanol):V (acetic acid)=9:1 mixed solution is washed off using soxhlet extraction method Template molecule and unreacted substance.
Currently preferred preparation method comprises the following steps:
S1. weigh a certain amount of template molecule camptothecine and function monomer MAA is dissolved in a certain amount of solvent, room temperature is shaken Prepolymerization is shaken, camptothecine is completely dissolved and forms stable hydrogen bond with MAA;
S2. crosslinking agent EGDMA and initiator A IBN is added in into the system after step S1 prepolymerizations, leads to N2Deoxidation, sealing After water bath with thermostatic control vibration polymerization under certain temperature;
S3. polymerizate taking-up is cooled to room temperature after the completion of the polymerisation described in step S2, centrifugal drying must polymerize Object;
S4. eluted template molecule and unreacted substance, until it can't detect template molecule in eluent, then with molten Agent washes away excessive acetic acid, is dried in vacuo to get to camptothecine microballoon namely camptothecine imprinted polymer (MIPs).
Preferably, solvent described in step S1 is mixed solvent, be methanol and chloroform according to volume ratio is 5~8:5~2 ratio Example determines.
Preferably, when the prepolymerized time described in step S1 is 1 small.
Preferably, the temperature of water bath with thermostatic control is 50 DEG C~60 DEG C, further preferred 60 DEG C under certain temperature described in step S2.
Preferably, when the time polymerizeing described in step S2 is 18 small.
Preferably, the logical N2The time of deoxidation is 10min.
Preferably, elution described in step S4 is using V (methanol):V (acetic acid)=9:1 mixed solution uses soxhlet extraction Method washes off template molecule and unreacted substance.Solvent described in step S4 is methanol.
What present invention offer the method was prepared obtains camptothecine microballoon.
Present invention simultaneously provides application of the camptothecine microballoon in terms of camptothecine is adsorbed, and printed particular as camptothecine Application of the mark polymer (MIPs) in terms of separating-purifying camptothecine.
Beneficial effects of the present invention are as follows:
The present invention provides a kind of methods for preparing camptothecine microballoon, are using the mixed solvent of methanol and chloroform as pore Agent, MAA are function monomer, and camptothecine is template molecule, and EGDMA is crosslinking agent, under the action of initiator, are vibrated through water-bath poly- It being obtained after dry after conjunction, elution, the camptothecine microballoon being prepared can be applied as microsphere material in chromatographic stationary phases, Efficient molecule distinguishability is shown, effective camplotheca acuminata alkali composition in complex extraction object is adsorbed, so as to reach what is isolated and purified Purpose.
The present invention uses MAA to obtain excellent polymerization effect for function monomer.The molecule knot of methacrylic acid (MAA) class Contain in structure there are one carbon-carbon double bond and a carboxyl, hydrogen bond can be generated with amino or carboxyl compound, it also can be in certain condition Lower and amine substance generates ionization, and higher choosing is shown as the molecularly imprinted polymer that function monomer synthesizes using it Select adsorptivity.
The present invention is realized creatively using the mixed solvent of methanol and chloroform as polymerisation by controlling mixing The amount of the methanol added in solvent controls the grain size of microballoon, for the extensive use of camptothecine microballoon provides strong technology branch It holding, the present invention further summarizes preferred solvent dosage and polymerization temperature, effectively controls the mobile performance of system in polymerisation, So as to regulate and control the optimal absorption property of microballoon.
The present invention determines adsorption isotherms of the MIPs under different camplotheca acuminata alkali concns, and MIPs has good compatibility Can, while probed into its absorption property with Scathard analytic approach.The molecularly imprinted polymer that present invention synthesis obtains is to mesh Molecule tool is marked there are two types of binding site, by using hydroxycamptothecin the making choice property adsorption experiment similar with camptothecine structure In, molecular engram microsphere shows Selective adsorption more higher than blank trace microballoon, and separation factor α is up to 2.09.With this hair Camptothecin molecule trace microballoon prepared by bright method is simple for process, and good high selection can be provided for camptothecin analogues and is inhaled Attached property material.
Description of the drawings
Standard curve of Fig. 1 camptothecines under 1~10 μ g/mL concentration.
The Dynamic Adsorption curve of Fig. 2 camptothecines MIPs.
The microballoon SEM figures of Fig. 3 different solvents ratio synthesis.
Influence of Fig. 4 different solvents dosage to the adsorption capacity of microballoon.
Influence of Fig. 5 function monomers dosage to the absorption property of microballoon.
The microballoon SEM figures of Fig. 6 difference in functionality monomer ratio synthesis.
Influence of the dosage of Fig. 7 crosslinking agents to microballoon absorption property.
The adsorption isotherm of Fig. 8 MIPs and NIPs.
Fig. 9 MIPs and NIPs is to the Scatchard analysis charts of the absorption property of camplotheca acuminata aqueous slkali.
Specific embodiment
It is further illustrated the present invention with reference to specific embodiment.Following embodiments are only for illustration, it is impossible to manage It solves as limitation of the present invention.Unless stated otherwise, the reagent used in following embodiments is that conventional purchased in market or commercial sources obtain The reagent obtained, unless stated otherwise, the method and apparatus used in following embodiments is method commonly used in the art and sets It is standby.
Embodiment 1
1. experiment reagent
Camptothecine (analyzes pure, Jinan Dai Zheng Co., Ltds);Camptothecine, hydroxycamptothecin (standard items, Chinese measuring science Research institute);α-methacrylic acid (MAA) (Tianjin Kermel Chemical Reagent Co., Ltd.);2 ' 2- azodiisobutyronitriles (AIBN, 98%), ethylene glycol dimethacrylate (EGDMA, 98%) (Aladdin reagent);Acetonitrile, methanol, chloroform, ice second Acid (analyzes pure, Tianjin great Mao chemical reagent factories).
2. laboratory apparatus
THZ-82 water-bath constant temperature oscillators, high honour instrument manufacturing Co., Ltd;KQ-300B type ultrasonic cleaners, Kunshan Ultrasonic instrument Co., Ltd of city;UV-2450 ultraviolet specrophotometers, agilent company;Environmental scanning electron microscope (SEM), the South China Botanical Garden Chinese Academy of Sciences;High performance liquid chromatograph, agilent company.
3. the synthesis microballoon of camptothecin molecule trace microballoon
It weighs a certain amount of template molecule camptothecine and function monomer MAA is dissolved in a certain amount of solvent, rocked at room temperature Prepolymerization 1h is completely dissolved camptothecine and forms stable hydrogen bond with MAA, adds in crosslinking agent EGDMA and initiator A IBN, lead to N2Deoxidation 10min is sealed after water bath with thermostatic control vibration polymerization 18h under certain temperature.Polymerizate taken out after the completion of reaction cold But to room temperature, centrifugal drying obtains polymer.With V (methanol):V (acetic acid)=9:1 mixed solution washes off mould using soxhlet extraction method Plate molecule and unreacted substance, until it can't detect template molecule in eluent, again with methanol washes away excessive acetic acid, Vacuum drying is to get to camptothecine imprinted polymer (MIPs).
Under conditions of template molecule is not added with, blank imprinted polymer (NIPs) is made in the same way.
The influence under different synthesis conditions to microballoon equilibrium adsorption capacity (Q), microballoon pattern is investigated in experiment using single_factor method, Main limit of consideration:
1. solvent selects:Acetonitrile, methanol, chloroform, methanol/chloroform mixed solvent
2. solvent dosage:15mL、20mL、30mL、40mL
3. mixed solvent ratio:V (methanol:Chloroform):5:5、6:4、7:3、8:2
4. synthesis temperature:50℃、55℃、60℃
5. function monomer dosage:Mol (camptothecines:MAA):1:2、1:4、1:6、1:8
6. dosage of crosslinking agent:Mol (camptothecines:EGDMA):1:10、1:15、1:20、1:30
1 different condition of table synthesizes camptothecin molecule trace microballoon
4.HPLC measures camptothecine content
(1) HPLC chromatogram condition:Experiment measures camptothecine content using high performance liquid chromatography, and chromatographic condition is:Chromatographic column: Kromasil 100-5C18 (4.6mm × 250mm, 5um);Column temperature:25℃;Flow velocity:1mL/min;Mobile phase:Acetonitrile/water (40/ 60, V:V);Sample size:20μL;Detection wavelength:254nm.It is filtered before sample feeding through 0.45 μm of organic phase filter membrane.
(2) preparation of standard solution:Camptothecin standard product 0.0034g accurately is weighed, uses methanol:Acetonitrile (1:1, V/V) it is molten Liquid dissolves and is settled to 10mL, obtains the camplotheca acuminata aqueous slkali of 0.976mmol/l.
(3) the Dynamic Adsorption experiment of imprinted polymer:
Six parts of 5mg camptothecin molecules imprinted polymers (MIPs) are weighed respectively, add in the camptothecine first of 10mL1mmol/L Alcohol:Acetonitrile (1:1, V/V) in solution, take out, centrifuge, organic phase is through 0.45 μm after shaken at room temperature 2h, 4h, 6h, 8h, 10h, 12h After membrane filtration, high performance liquid chromatography measures C before absorption1, C after absorption2The concentration of camptothecine, calculates Dynamic Adsorption in solution Test the adsorption capacity Q of each period.
In formula (I):
C1:Concentration (mmol/g) before absorption
C2:Concentration (mmol/g) after absorption
V:Adsorbent solution volume (mL)
m:Polymer quality (mg)
(4) equilibrium adsorption experiment
5mg polymer is weighed, adds in the camptothecine methanol of 10mL, 1mmol/L:Acetonitrile (1:1, V/V) chromatographically pure solution, room Temperature vibration centrifuges solution after must adsorbing after a certain period of time, and the content of camptothecine in solution is measured by high performance liquid chromatography.Pass through Formula (I) calculates equilibrium adsorption capacities Q, and camptothecin molecule trace microballoon is synthesized come each factor of comparison by adsorption capacity values It influences.
(5) adsorption isotherm
It is accurate to weigh each 5mg of MIPs and NIPs, add in the camptothecine methanol of certain volume various concentration:Chloroform (1:1, V/ V) chromatographically pure solution, at room temperature vibration absorption certain time, centrifugation, takes supernatant liquor to be measured by high performance chromatograph in solution and likes Set the content of alkali.Adsorption capacity Q is calculated, and adsorption isotherm is drawn according to the variation of adsorption capacity.
(6) the Selective adsorption experiment of microballoon
The competitive Adsorption experiment of MIPs:Camptothecine, the hydroxycamptothecin chromatographically pure solution of isoconcentration are prepared respectively, it is each to add in The MIPs and NIPs of 5mg, to measure its dense for high performance liquid chromatography under 254nm, 266nm respectively after a certain period of time for shaken at room temperature absorption Degree compares the adsorbance of the two.
(7) scanning electron microscope
The microballoon of the drying prepared is sticked on double faced adhesive tape, vacuum metal spraying, observed with scanning electron microscope (SEM) micro- Spherical looks, and from SEM figures measure 50~100 microballoons grain size, calculate average grain diameter.
5. experimental result
(1) drafting of camptothecin standard curve
Measure camptothecine using high performance liquid chromatography is in the linear equation of methanol/acetonitrile mixed solution:Y=91.776x+ 4.342,R2=0.9998.Standard curve of the camptothecine under 1~10 μ g/mL concentration is as shown in Figure 1.
(2) the Dynamic Adsorption curve of imprinted polymer
Dynamic Adsorption curve is made as shown in Figure 2 in adsorption capacity in different time periods according to MIPs.Experiment is found MIPs initial absorbing rates are very fast, and maximal absorptive capacity is reached after 4h, and as the time increases, adsorbance, which tapers into, finally to exist 10~12h tends towards stability.The reason is that since saturation has not yet been reached in the binding site in microballoon when just starting absorption, still have and mould The ability that plate molecule combines, with the increase of adsorption time, adsorbance also gradually increases;When adsorption time reaches 4h, polymerization Object surface void has been occupied, and the camptothecin molecule to dissociate in solution, which reaches internal cavity, needs the longer time, while when molten The concentration of camptothecine reduces in liquid, and outer the phenomenon that spitting can occur for the polymer that part surface has adsorbed template molecule so that absorption Amount reduces.Dynamic Adsorption finally reaches adsorption equilibrium after 10~12h.
(3) optimizing research of camptothecin molecule trace microballoon synthesis condition and experiment
Solvent determines:
Experiment finds that solubility of the camptothecine in all kinds of solvents is relatively low, can only be dissolved in pyridine, chloroform, dichloromethane, first Alcohol/chloroform mixed solution etc..Lot of experiments is summarized, it is found that camptothecine dissolubility in chloroform, dichloromethane is best.Initial stage Polymerisation is carried out using single chloroformic solution, but because chloroform is volatile, volatilization is easy in heat polymerization process completely, is led Cause the product ultimately generated caking, it is difficult to collect.Therefore a certain proportion of methanol is creatively added in system, increase solution pole Property, reduce solution evaporation amount in reaction.
In the case where other conditions are constant, polymerization temperature is 60 DEG C, and camplotheca acuminata alkali concn is 4.167mmol/L, and template is divided Son:Function monomer:Crosslinker ratio is 1:4:20, change the ratio of methanol and chloroform, by compare equilibrium adsorption capacities Q and Pass through the change of size of scanning electron microscopic observation microballoon.
Fig. 3 show the microballoon SEM figures of different solvents ratio synthesis.It can be seen that suction of the change of solvent ratios to microballoon Attached performance influence is simultaneously little, but has been largely fixed the size of microspherulite diameter.When methanol content is more, polymerization system Polarity, viscosity and surface tension it is bigger, the mass transfer rate of system is caused to reduce, the aggregation velocity of polymer segment slows down, gather The surface tension increase that synthesis ball needs overcome, the MIPs grain sizes of formation are smaller.Conversely, methanol content is reduced, chloroform content increases Add, polarity, the surface tension of polymerization system reduce, and are more advantageous to the formation of big grain size MIPMs.Chloroform and methanol in polymerization system Addition be the key that influence MIPs particle sizes, methanol is unfavorable for the balling-up of big ball, and chloroform is then conducive to generate big grain The MIPs in footpath.Grain size is smaller, and microsphere surface product is bigger, can definitely increase with respect to its absorption property.It is closed using precipitation polymerization method The ratio of methanol and chloroform according to practical application, can be changed into camptothecine microballoon, to achieve the purpose that control the size of microballoon.
Influence of the 2 different solvents ratio of table to microballoon absorption property
Solvent dosage determines:
Keep other conditions constant, the present embodiment is with the preferable value range of solvent dosage that numerous studies of the present invention determine In 15mL~40mL, change solvent dosage 15mL, 20mL, 30mL, 40mL as representative, the concentration for being corresponding in turn to camptothecine is: 8.33mmol/L、6.25mmol/L、4.167mmol/L、3.15mmol/L.Fig. 4 show suction of the different solvents dosage to microballoon The influence of attached ability.By researching and analysing and comparing the adsorption capacity of polymer obtained under various concentration to template molecule, really Fixed optimal dosage.
Solvent capacity is formed with important role to polymer, as the reduction of solvent dosage causes system mobility to drop Low, viscosity increase, monomer molecule movement is difficult, and polymer critical chain length increases, and wraps up the degree of function monomer and reduces, core aggregation Polymer particle number declines, and when polymerization easily generates bonding, and the reactant frequently resulted in bonds blocking, that is, becomes tube sealing polymerization Mode causes elution difficulty and increases, and then influences the adsorbance of microballoon.In 30mL, i.e. camplotheca acuminata alkali concn exists solvent During 4.167mmol/L, adsorption capacity reaches maximum, and the viscosity of reaction system solvent reaches optimum capacity, and continuing, which increases solvent, holds Amount, monomer concentration reduce, and crosslinked polymer is spent low, cannot partly be reacted completely, be caused the reduction of adsorption capacity.
Reaction temperature determines:Other reaction conditions are constant, and the present embodiment is anti-with the polymerization that numerous studies of the present invention determine It selects 50 DEG C, 55 DEG C, 60 DEG C to be illustrated as representative in 50 DEG C~60 DEG C of the preferable temperature range answered, investigates different temperatures Under influence to Macroscopic single crystal, be shown in Table 3.
Influence of 3 synthesis temperature of table to the character of microballoon
When polymerization temperature is 60 DEG C, the absorption property of the MIPs of preparation is best, and character is preferably also.Synthesis temperature determines Reaction system viscosity size when temperature is more than 60 DEG C, causes polymerization speed to be accelerated, polymer chain is elongated, microsphere mass transfer Become difficult, while volatile solvent easily escapes in system, mobility is reduced, the microballoon caking of generation;Temperature is too low, generation Polymer rigid it is too small, be unable to maintain that opening structure, and react incomplete, and the reactant formed under too low synthesis temperature A kind of state of jello is presented in mixture.
The dosage of function monomer determines:In the case where other conditions are constant, CPT concentration is 4.165mmol/L, changes mould The ratio of plate molecule and function monomer, the present embodiment is with ratio 1:2、1:4、1:6、1:8 illustrate.Fig. 5 show function list Influence situation of the body dosage to the absorption property of microballoon.Fig. 6 show the microballoon SEM figures of difference in functionality monomer ratio synthesis.It can Work as camptothecine to see:MAA molar ratios are 1:When 4, adsorbance reaches maximum.The amount of increase MAA is conducive to itself and camptothecine shape Into the polymer with hole trace, when molar ratio is 1:When 4, the hole that can be combined in function monomer with template molecule just reaches To saturation, the association of MAA itself can only be increased by continuing increase, influence the absorption property of microballoon.In general, in dispersion The monomer of low concentration is more advantageous to being formed the microballoon of grain size bigger[67-68].When monomer concentration is relatively low, polymerization initial stage is formed Less oligomer core, therefore more free monomers diffuse to the surface of core with crosslinking agent, gradually form the microballoon of bigger.By SEM electron microscopes can find that monomer concentration increases, and microspherulite diameter is smaller.
The dosage of crosslinking agent determines:It keeps other conditions constant, changes the ratio of template molecule and dosage of crosslinking agent, this reality Example is applied with 1:10、1:15、1:20、1:It is illustrated exemplified by 30, the concentration (w/v, g/l) for being corresponding in turn to crosslinking agent is:8.26%th, 12.39%th, 16.52%, 24.77%.Fig. 7 show influence situation of the dosage of crosslinking agent to microballoon absorption property.Work as crosslinking The absorption property for the molecularly imprinted polymer that agent dosage obtains when too high or too low is not ideal, and experiment obtains working as function monomer It is 1 with crosslinker ratio:When 15, the absorption property of microballoon is optimal.Influence of the degree of cross linking to polymer beads Mesoporous property is close Related cross-links agent dosage is too small, and the viscosity of polymerization system is reduced, and crosslinking points tail off, and influence the knot of template molecule and function monomer It closes, while in elution process, macromolecule aggregation state easily adjusts, and makes poroid being destroyed of polymerization stage formation, destroys The binding site with template molecule that originally forms influences the absorption property of microballoon.Dosage of crosslinking agent is excessive, although formed Polymer orifices are relatively stablized, but aperture becomes smaller, and influences mass transfer of the template molecule to polymeric inner, cause absorption property under Drop.
The absorption property of 2 microsphere microballoon (MIPs) of embodiment compares
The microsphere microballoon (MIPs) and blank microsphere (NIPs) prepared with the present invention is under various concentration to mesh The adsorption capacity of molecule camptothecine is marked, draws the adsorption isotherm of polymer, as shown in Figure 8.As can be seen that the absorption of polymer Capacity increases with the increase of camplotheca acuminata alkali concn, finally tends to balance.When concentration is relatively low, the adsorption site of polymer is not satisfied also With, polymer to the target molecule in solution also there is adsorption capacity, and when concentration gradually increases, a certain amount of microsphere gathers The adsorption capacity for closing object reaches saturation, and adsorption capacity is not further added by and tends to saturation state.
Imprinted polymer is compared with the adsorption capacity of non-imprinted polymer big simultaneously, it was demonstrated that the imprinted polymer of synthesis is to template Molecule has higher affinity and specific recognition.
Gas selectivity α, microsphere β are introduced to compare the selectivity of microsphere and non-microsphere:
In formula (II):Cp:During adsorption equilibrium in polymer camptothecine concentration (μm ol/g);
Cs:During adsorption equilibrium in solution camptothecine concentration (mmol/L).
In formula (III), (IV), Kd,M:The equilibrium dissociation constant of imprinted polymer;
Kd,N:The equilibrium dissociation constant of non-imprinted polymer.
Wherein, separation factor α represents selectivity of the microsphere to template molecule and its analogue, be generally separated because Sub- α>1.5, that is, think that the microsphere polymer has template molecule special selection identity.Microsphere β representatives are being detained After non-selection absorption, microsphere polymer is to the ability of template molecule, general microsphere β>0.5, that is, think MIPs ratios NIPs has significant difference to template molecule, and imprinting effect is good.As shown in table 2, table 3, it can be seen that when solution concentration (0.5~ 1.5) in the range of mmol/L, microsphere β is all higher than 0.5, MIPs has significant otherness than NIPs, has better choice Recognition capability.
The imprinting factor of MIPs and NIPs under 4 various concentration of table
Scatchard analyses are carried out to the absorption property of polymer, equation is:
In formula (V), C be template molecule equilibrium concentration, QmaxFor maximum apparent adsorption quantity.
Fig. 9 show Scatchard analysis charts of the MIPs and NIPs to the absorption property of camplotheca acuminata aqueous slkali.By left in Fig. 9 Figure understands that for Q/C and Q in non-linear relation, this is very universal in non-covalent type molecularly imprinted polymer, illustrates MIPs microballoons pair Template molecule is anisotropic there are two kinds of different adsorption sites.The reason for generating two kinds of different binding sites may be Function monomer MAA and template molecule camptothecine are combined with different proportionings during self assembly, form two Kind imprinted cavity of different nature.It is acquired by the slope and intercept of seeking two straight lines, equilibrium dissociation constant is respectively:
Kd1=1.306mmol/l, Kd2=0.323mmol/L;
Maximum apparent adsorption quantity is:Qmax1=120.22 μm of ol/g, Qmax2=71.65 μm of ol/g.
Rather than the scatchard analysis charts of imprinted polymer are linearly distributed, i.e., its adsorption site is isotropism, is reacted A kind of binding site has been only formed in the process, that is to say, that NIPs is in non-selective adsorption to the adsorptivity of template molecule.
The Selective adsorption experiment of 3 microsphere microballoon (MIPs) of embodiment
Both experiment uses hydroxycamptothecin the making choice property adsorption experiment similar with camptothecine structure, by comparing Adsorption capacity size investigates the specific selection adsorptivity of microballoon.
5 MIPs of table compares the absorption property of camptothecine, hydroxycamptothecin
From upper table 5, MIPs is to the adsorbance of target molecule camptothecine apparently higher than the adsorbance to hydroxycamptothecin. Separation factor α is 1.83~2.09, is all higher than 1.5, shows to select recognition capability well.This is because polymer MIPs exists Form the stereochemical structure trace hole to match with template molecule (camptothecine) size, form during synthesis, and NIPs simply by Function monomer is formed with crosslinking agent reactive polymeric, and formation is random, the smaller particle of grain size, does not identify position specifically Point.It can prove that MIPs produced by the present invention has camptothecine special Selective adsorption.

Claims (10)

1. a kind of preparation method of camptothecine microballoon, which is characterized in that be using the mixed solvent of methanol and chloroform as pore-foaming agent, MAA is function monomer, and camptothecine is template molecule, and EGDMA is crosslinking agent, under the action of initiator, vibrates and polymerize through water-bath It is obtained after dry afterwards, elution.
2. the preparation method of camptothecine microballoon according to claim 1, which is characterized in that be by controlling in the mixed solvent first The amount of alcohol controls the grain size of microballoon;It is preferred that the volume ratio of the in the mixed solvent, methanol and chloroform is 5~8:5~2.
3. the preparation method of camptothecine microballoon according to claim 1, which is characterized in that the dosage of the mixed solvent according to The gauge of 1moL template molecules, the solvent of addition is 15~40mL;The solvent being preferably added to is 30mL;The temperature of the polymerization For 50 DEG C~60 DEG C, preferably 60 DEG C;When the time of the polymerization is 18 small.
4. the preparation method of camptothecine microballoon according to claim 1, which is characterized in that the dosage of the function monomer according to The mol ratio of itself and template molecule is 2~8:1 determines;The dosage of the crosslinking agent is according to its mol ratio with template molecule For 10~30:1 determines;It is preferred that the mol ratio of the template molecule, function monomer, crosslinking agent is 1:5:15.
5. the preparation method of camptothecine microballoon according to claim 1, which is characterized in that the initiator is different using azo two Butyronitrile or azo diamyl cyanogen.
6. according to the preparation method of any one of claim 1 to the 5 camptothecine microballoon, which is characterized in that comprise the following steps:
S1. weigh a certain amount of template molecule camptothecine and function monomer MAA is dissolved in a certain amount of solvent, rocked at room temperature is pre- Polymerization, is completely dissolved camptothecine and forms stable hydrogen bond with MAA;
S2. crosslinking agent EGDMA and initiator A IBN is added in into the system after step S1 prepolymerizations, leads to N2 deoxidations, seal after Water bath with thermostatic control vibration polymerization under certain temperature;
S3. polymerizate taking-up is cooled to room temperature after the completion of the polymerisation described in step S2, centrifugal drying obtains polymer;
S4. eluted template molecule and unreacted substance, are washed until it can't detect template molecule in eluent, then with solvent Excessive acetic acid is removed, is dried in vacuo to get to camptothecine microballoon.
7. the preparation method of camptothecine microballoon according to claim 8, which is characterized in that solvent described in step S1 is molten to mix It is 5~8 that agent, which is methanol and chloroform, according to volume ratio:5~2 ratio-dependent;When the prepolymerized time described in step S1 is 1 small; The temperature of water bath with thermostatic control described in step S2 is 50 DEG C~60 DEG C;When the time polymerizeing described in step S2 is 18 small.
8. the preparation method of camptothecine microballoon according to claim 8, which is characterized in that lead to N2 deoxidations described in step S2 Time is 10 min;Elution described in step S4 is using V (methanol):V (acetic acid)=9:1 mixed solution uses soxhlet extraction method Wash off template molecule and unreacted substance;Solvent described in step S4 is methanol.
9. the camptothecine microballoon that the preparation method of any one of claim 1 to the 8 camptothecine microballoon is prepared.
10. application of the camptothecine microballoon as camptothecine imprinted polymer in terms of separating-purifying camptothecine described in claim 9.
CN201711077310.3A 2017-11-03 2017-11-03 The preparation method and application of camptothecine microballoon Pending CN108047484A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711077310.3A CN108047484A (en) 2017-11-03 2017-11-03 The preparation method and application of camptothecine microballoon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711077310.3A CN108047484A (en) 2017-11-03 2017-11-03 The preparation method and application of camptothecine microballoon

Publications (1)

Publication Number Publication Date
CN108047484A true CN108047484A (en) 2018-05-18

Family

ID=62118747

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711077310.3A Pending CN108047484A (en) 2017-11-03 2017-11-03 The preparation method and application of camptothecine microballoon

Country Status (1)

Country Link
CN (1) CN108047484A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113996275A (en) * 2021-11-23 2022-02-01 东北林业大学 Preparation of camptothecin molecularly imprinted polymer and method for separating and purifying camptothecin from camptotheca acuminata fruits

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102070750A (en) * 2010-12-02 2011-05-25 浙江大学 Method for preparing sumicidin molecularly imprinted polymer microspheres
CN102382247A (en) * 2010-09-03 2012-03-21 中国科学院过程工程研究所 Preparation method of molecular imprinting polymer micro-sphere with uniform size and application
CN102731706A (en) * 2012-06-20 2012-10-17 浙江省农业科学院 Carbofuran molecularly imprinted microspheres, preparation and application thereof
CN103497277A (en) * 2013-09-09 2014-01-08 南京医科大学 Baicalein molecularly imprinted polymer, preparation method and application thereof
US20150160207A1 (en) * 2010-07-06 2015-06-11 Aptateck Bio Ltd. Nucleic acid aptamer-based diagnostic methods with novel techniques for signal enhancement

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150160207A1 (en) * 2010-07-06 2015-06-11 Aptateck Bio Ltd. Nucleic acid aptamer-based diagnostic methods with novel techniques for signal enhancement
CN102382247A (en) * 2010-09-03 2012-03-21 中国科学院过程工程研究所 Preparation method of molecular imprinting polymer micro-sphere with uniform size and application
CN102070750A (en) * 2010-12-02 2011-05-25 浙江大学 Method for preparing sumicidin molecularly imprinted polymer microspheres
CN102731706A (en) * 2012-06-20 2012-10-17 浙江省农业科学院 Carbofuran molecularly imprinted microspheres, preparation and application thereof
CN103497277A (en) * 2013-09-09 2014-01-08 南京医科大学 Baicalein molecularly imprinted polymer, preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
周昱喆: ""喜树碱功能微球合成及其性能研究"", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113996275A (en) * 2021-11-23 2022-02-01 东北林业大学 Preparation of camptothecin molecularly imprinted polymer and method for separating and purifying camptothecin from camptotheca acuminata fruits
CN113996275B (en) * 2021-11-23 2024-04-19 东北林业大学 Preparation of camptothecine molecularly imprinted polymer and method for separating and purifying camptothecine in camptotheca acuminata fruits

Similar Documents

Publication Publication Date Title
Huang et al. Molecularly imprinted monolithic stationary phases for liquid chromatographic separation of enantiomers and diastereomers
Xu et al. Molecularly imprinted core-shell nanoparticles for determination of trace atrazine by reversible addition–fragmentation chain transfer surface imprinting
Yan et al. Simultaneous determination of four plant hormones in bananas by molecularly imprinted solid-phase extraction coupled with high performance liquid chromatography
Moein et al. Molecularly imprinted sol-gel nanofibers based solid phase microextraction coupled on-line with high performance liquid chromatography for selective determination of acesulfame
US4613442A (en) Novel optically active polymer, preparation and use
Zhu et al. Using ionic liquid monomer to improve the selective recognition performance of surface imprinted polymer for sulfamonomethoxine in strong polar medium
Liu et al. Pillarene functionalized polymer monolithic column for the solid-phase microextraction preconcentration of parabens
CN109331794A (en) A kind of dopamine and its metabolin molecular engram magnetic nano-balls and its preparation method and application
CN109232782A (en) A kind of preparation method for the molecularly imprinted polymer targeting adsorbing separation taxol
CA2445211C (en) Copolymer, and adsorbent or concentrating medium and needle for solid phase microextraction prepared using the copolymer
CN108047484A (en) The preparation method and application of camptothecine microballoon
CN108623834A (en) The remaining method of triazine herbicide in molecular engram-dispersive solid-phase extraction detection agricultural product
Yan et al. Fabrication of cellulose derivative coated spherical covalent organic frameworks as chiral stationary phases for high-performance liquid chromatographic enantioseparation
CN107286304A (en) Acryloyl group beta cyclodextrin POSS Fe3O4Magnetic particle is synthesized and applied
CN108586652B (en) A kind of chirality organometallic skeletal hollow nano-sphere and the preparation method and application thereof
CN108084341B (en) Synthesis method and application of crystal violet molecularly imprinted microspheres
CN101591412B (en) Method for preparing chloramphenicol molecularly imprinted polymeric microspheres
CN110590998B (en) Synthesis method and application of sulfonamide dimethylpyrimidine molecularly imprinted polymer
CN106279488B (en) The preparation for the molecularly imprinted polymer that three kinds of alkaloids of sandliving sophora seed extract at the same time and extracting process
CN109096434B (en) Triazole molecularly imprinted polymer microsphere and preparation method and application thereof
Liu et al. Molecularly imprinted polymers coated on carbon nanotubes for matrix solid phase dispersion extraction of camptothecin from Camptotheca acuminate
CN105801751A (en) Preparation and application of MIP (molecularly imprinted polymer) with tropane alkaloid drug specificity
CN1718593A (en) A kind of preparation method of molecularly imprinted polymer
CN105504159B (en) A kind of bonded chiral amino alkoxide polymer and its preparation method and application
CN110404584A (en) A kind of 4-methyl umbelliferone molecular engram nanofiber, preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Jiang Xuhong

Inventor after: Cheng Xingan

Inventor after: Liu Zhanmei

Inventor after: Wu Bo

Inventor after: Ye Jingmin

Inventor before: Cheng Xingan

Inventor before: Jiang Xuhong

Inventor before: Liu Zhanmei

Inventor before: Wu Bo

Inventor before: Ye Jingmin

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180518